Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > new drugs, very strategic

<< Previous

Bullboard Posts

Next >>

Comment by WarrantOfficeron Sep 12, 2024 9:20am

93 Views

Post# 36220044

RE:RE:RE:RE:RE:new drugs, very strategic

As a career soldier I was always aware of traction, either back, sideways or forward. Management "nitpicking", for myself in particular, a natural human response for not fully comprehending the intricacies of the pharma sector and the perceived lack of information funneled down to the shareholder.

I am fully cognizant of the potential Voyageur offers and do feel that in the future, one morning we are all going to wake up with a $1 SP and from there it is going to get really interesting.

<< Previous

Bullboard Posts

Next >>

These cold weather stocks are looking to heat up for winter